Ascorbic acid deficiency impairs wound healing in surgical patients: Four case reports  by Bikker, A. et al.
Case Report
Ascorbic acid deﬁciency impairs wound healing in surgical patients:
Four case reports
A. Bikker a,*, J. Wielders a, R. van Loo a, M. Loubert b
a Dept. of Clinical Chemistry, Meander Medical Center, Amersfoort, The Netherlands
b Dept. of Surgery, Meander Medical Center, Amersfoort, The Netherlands
A R T I C L E I N F O
Article history:
Received 6 November 2015
Received in revised form 17 February 2016
Accepted 20 February 2016
Available online 2 March 2016
Keywords:
Case reports
Vitamin C
Wound healing
Ascorbic acid
Wound care
A B S T R A C T
Background: Vitamin C or ascorbic acid (AA) is the antiscorbutic factor preventing scurvy. It is essen-
tial for collagen synthesis, serving as cofactor in the enzymatic conversion of procollagen into collagen.
Scurvy is regarded as something from the past; however, patients with low or subclinical levels of
AA are frequently seen in our hospital. A subclinical deﬁciency will not often cause the display of the
hallmark symptoms of scurvy, but this may lead to an altered collagen synthesis and have major impli-
cations for adequate wound healing, such as in the surgical ﬁeld.
Case summary: AA was measured by HPLC using UV detection (Recipe) in a teaching hospital surgical
patient group (n = 180) within a week pre- or post-surgery. Over a period of 21 months we found AA
levels below the reference limit (25 umol/L) in 65 out of 180 patients (36%). Four patients described in
detail initially showed poor wound healing. Their AA levels were 8, 4, and 19 umol/L respectively. After
starting supplementation (1000mg/day) a dramatic and fast recovery of extensive and complicated wounds
was observed by patients and their clinician. Supplementation was ceased after the wounds were com-
pletely healed.
Conclusion: AA deﬁciency is not uncommon in the hospital population, especially in those at risk. Treat-
ing deﬁcient patients with AA leads to swift improvement of the wound healing process post-surgery,
thereby reducing the costs of extensive wound treatment and extended stay in hospital.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Classically, major complications caused by AA deﬁciency are seen
in scurvy patients; however, patients nowadays often do not display
these hallmark characteristics. Individuals suffering from vascular
disease, elderly people, pregnant women, smokers and substance
abusers, and malnourished people are especially prone to AA de-
ﬁciency. This is demonstrated by the four cases reported below. These
patients were all at increased risk of developing an AA deﬁciency,
which in turn resulted in poor wound healing. Treatment of these
patients with AA resulted in a rapid improvement of wound healing.
2. Case report 1
A 59-year-old man underwent an exploratory laprotomy in our
hospital for abdominal pain caused by diverticulitis, for which he
received appendectomy and sigmoid colectomy. Postoperatively, he
suffered twice from an abdominal wound dehiscence, which was
surgically corrected (Fig. 1A), the second time with polyglactin mesh
interposition, for which the wound was left open (wound size
30 × 25 cm). Unfortunately, the healing process did not show im-
provement, despite optimal wound care with alginate dressings
(Fig. 1B and C). After 6 weeks with little result the patient was told
to take AA suppletion of 1000mg dd orally. No changes were made
in his wound dressing regime. Healthy granulation tissue was seen
after 2.5 weeks, and the wound size was reduced to one third of
its original size (Fig. 1D and E). 2.5 months after start of AA supple-
mentation the wound was fully closed (Fig. 1F). As a result of this
case, we decided to conduct a retrospective study in a group of sur-
gical patients with poor wound healing that had their AAmeasured.
Three additional cases are described in detail below.
3. Case report 2
A 79-year-old woman with an extensive medical history, in-
cluding asthma, severe chronic obstructive pulmonary disease,
degenerative spondylolisthesis, total left and right hip replace-
ment, rheumatoid arthritis, and chronic venous insuﬃciency (grade
IV) was admitted to the Meander Medical Center with severe leg
* Corresponding author. Laboratory for Clinical Chemistry, Maatweg 3 3813 TZ
Amersfoort, P.O. Box 1502, 3800 BM Amersfoort, The Netherlands. Tel.: +31 33 850
2057, fax: +31 33 850 2035.
E-mail addresses: a.bikker@meandermc.nl/angela.bikker@gmail.com (A. Bikker).
http://dx.doi.org/10.1016/j.ijso.2016.02.009
2405-8572/© 2016 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
International Journal of Surgery Open 2 (2016) 15–18
Contents lists available at ScienceDirect
International Journal of Surgery Open
journal homepage: www.elsevier.com/ locate / i jso
ulcers. She underwent a surgical intervention to remove necrotic
tissue and her wounds were treated by pinch grafting. Her wounds
were dressed post-operatively with Aquacel Ag and dressings were
changed when necessary. Unfortunately her post-operative wounds
remained ulcerative and showed no progression toward healing. Her
treatment was continued with Fluocinonide and Aquacel Ag three
times weekly, and her wounds were additionally dressed with foam
dressing, and after a month of treatment her wounds seemed to heal
accordingly. After two months, however, she returned with a new
wound, which was treated with a foam dressing and Cutimed
Sorbact. After 9 months of extensive and optimal wound care with
disappointing results her vitamin status was measured. Vitamin D
(100 nmol/L), B12 (240 pmol/L) en folate (10.5 nmol/L) levels were
in the normal range, but her AA level was very low (8 umol/L, ref-
erence range 25–85 umol/L). Other laboratory parameters showed
a slight normocytic anemia, but no further abnormalities. The patient
was immediately started on AA supplementation, 1000 mg a day
(effervescent tablet), and after 3 to 4 weeks the patient noticed a
signiﬁcant improvement. After 8 weeks her ulcers were com-
pletely healed and supplementation was discontinued.
4. Case report 3
A second case involves a 68-year-old woman, again with an ex-
tensive medical history, including Crohn’s disease, hypertension,
diabetes type 2, cardiovascular disease, and thyroiditis as a result
of amiodarone use. She had undergone an ileocecal resection cor-
recting a perforation of the terminal ileum and as a result developed
a severe case of peritonitis. Her post-surgery AA level was found
to be 4 umol/L; other vitamins measured were active vitamin B12
75 pmol/L (ref. >21 pmol/L), B1 was 179 nmol/L (ref. 88–157 nmol/
L), B6 was 83 nmol/L (ref. 35–110 nmol/L), and D3 27 nmol/L (ref.
50–132 nmol/L). Due to her Crohn’s disease she had a slightly de-
creased albumin level (23 g/L, ref. 29–46 g/L), and a history of anemia
of the chronic disease. After 2 months she had to undergo another
emergency laparotomy because of an anastomotic leakage, result-
ing in the construction of a loop ileostomy. Surprisingly, a poorly
healed laparotomy closure from her previous surgery was ob-
served and the abdominal fascia hardly showed any closure at all.
She also suffered frommultiple perforations of the transverse colon
for which a wedge resection and side-to-side anastomosis was per-
formed. Shortly after, shewas started on 2 × 500mg AA intravenously
during two weeks and 2 × 500 mg AA orally for two weeks after
which no further surgery was needed.
5. Case report 4
The last patient being discussed is a 56-year-old man who was
diagnosed with thromboangiitis obliterans (Buerger disease) as a
result of nicotine abuse. He suffered from a deep, indolent, and ul-
cerative wound on the lateral surface of his right ankle (Fontaine
stage IV). The wound was ischemic due to arterial insuﬃciency
caused by his disease, and was intensely painful. Furthermore, a
wound culture showed the presence of several bacteria (Staphylo-
coccus aureus, Streptococcus dysgalactiae, Pseudomonas aeruginosa,
and Escherichia coli). Unfortunately, no revascularization surgery was
possible, because of far advanced vascular damage to his lower leg
arteries. The patient was told to quit smoking and was started on
1 ng/kg/min iloprost (prostacyclin analogue) i.v. therapy for a total
of three weeks in order to improve wound healing by relieving isch-
emic symptoms. In the ﬁrst week of treatment his laboratory results
showed a low AA level of 19 umol/L. Vitamin B12 (202 pmol/L), folic
acid (8.4 nmol/L), vitamin D (90 nmol/L), and other laboratory pa-
rameters (hemoglobin, platelets, creatinine, CRP) were normal. This
Fig. 1. Post-operation pictures taken by the patient showing an abdominal wound dehiscence and inadequate wound healing (A, B, C), and after ascorbic acid supplemen-
tation showing healthy granulation tissue (D, E) and full closure after 2.5 months (F).
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prompted us to start with AA supplementation (500 mg, 2 dd). In
one study comparing iloprost i.v. (1 ng/kg/min for 28 days) versus
placebo treatment in Buerger disease patients, a complete healing
rate of 62% vs. 41% respectively was observed at week 4 and 85%
vs. 52% respectively at week 24 [1]. Our patient showed a full re-
covery after 3 weeks from a very deep and infected ulcer with this
combination therapy of iloprost and AA.
6. Discussion
In our population of surgical patients (n = 180) we measured AA
levels (HPLC using UV detection [Recipe kit], average cost per AA
blood analysis €20,–/$22,–), because they displayed poor wound
healing, despite adequate wound care. In 65 out of 180 patients (36%)
AA levels were below the reference limit of 25 umol/L, demonstrat-
ing a signiﬁcant prevalence of AA deﬁciency in our pilot hospital
population.
As has been elaborately demonstrated in previous studies, AA
plays a pivotal role in collagen synthesis, where it catalyzes the con-
version of procollagen to collagen by substitution of a hydroxyl group
for a hydrogen atom thereby acting as a reducing agent [2].
Dermal wound healing consists of three stages, i.e. connective
tissue matrix deposition, contraction and epithelialization. This is
preceded by a phase of hemostasis and inﬂammatory activation.
During tissue matrix deposition, collagen, proteoglycans and at-
tachment proteins are deposited to create a new extracellular matrix.
The so-called myoﬁbroblasts are responsible for contraction and are
dependent on AA for the production collagen [3]. Epithelialization
in turn also depends on AA, as this high metabolic process re-
quires increasing amounts of nutrients and oxygen. Hypoxia-
inducible factor-1a (HIF-1α) is therefore upregulated by vascular
endothelial cells to increase angiogenesis by regulating vascular en-
dothelial cell growth factor (VEGF) [4]. The healing process comprises
an interplay of ﬁbroblasts, epithelial cells, cytokines, and immune
cells. Neutrophils and specialized macrophages play an important
role in removing bacteria and tissue debris. In order to do so, they
need to phagocytize and break down these harmful pathogens for
which it is believed they need AA [5]. In fact, circulating white blood
cells contain 10–30 times the plasma concentration of AA [6]. By
adding the effect on inhibition of reactive oxygen species (ROS) for-
mation in tissue cells, it is easy to see how AA deﬁciency could lead
to ineffective wound healing [7].
AA is water-soluble and absorbed in the distal small intestine,
where an average dose of up to 200 mg/day can be completely ab-
sorbed [8]. With higher doses given orally the relative absorption
decreases. Dietary reference intakes for AA have been established
at 90 mg for men and 75 mg for women [9]. Daily ingestion of at
least 60 mg of AA should result in a body pool of 1500 mg [10]. A
minimum of 45 mg/day should prevent scurvy in a healthy indi-
vidual; correcting an AA deﬁcit in scurvy patients takes an oral intake
of at least 100mg three times a day [11]. A meta-analysis of 44 clin-
ical trials has shown a signiﬁcant positive effect of AA on endothelial
function when taken at doses greater than 500 mg per day. It was
also found that the effect of supplementation appeared to be de-
pendent on health status, with stronger effects in those at higher
cardiovascular disease risk [12].
There is still no consensus about the therapeutic effects and
dosage of AA, and several randomized control trials (RCTs) have
shown no effect of antioxidant supplement on mortality and mor-
bidity outcomes [13]. With regard to wound healing only two RCTs
have been conducted [14,15]. Statistical analysis of both trials in this
review showed that therewas no evidence of a beneﬁt of oral supple-
mentation with AA (500 mg 2dd) on pressure ulcer healing [16].
In the ﬁrst study by Taylor et al. [14] AA levels in both groups
were on average not deﬁcient (24 and 22 μg/108 leukocytes; deﬁ-
ciency is deﬁned as <18 μg/108 leukocytes). Only 3 individuals in
the placebo group and 2 in the AA intervention group showed an
AA level lower than 18 μg/108 leukocytes. In the second study by
ter Riet et al. [15] 37% of the ascorbic intervention group and 49%
of the control group were not deﬁcient and the control group re-
ceived supplementation as well (10 mg AA 2dd orally).
In our three cases, concentrations well above the required dose
of AA for treating scurvy were given, and for these and other cases
a rapid improvement of wound healing within a few days to weeks
after starting AA therapy was seen. Noteworthy, the route of ad-
ministration might also have implications for its therapeutic effect.
As oral doses exceed 200 mg the relative absorption decreases, ex-
cretion in urine increases, thereby reducing the bioavailability of
AA [17].
This said, evidence from our cases shows that oral administra-
tion does have the potential to induce the regenerating properties
of AA. Most likely, it is also dependent on the AA tissue storage prior
to administration, and more importantly, pathological and other
events (e.g. surgery) that trigger rapid AA loss.
7. Conclusion
Regarding the cases presented here, orally administered doses
of ascorbic acid supplemented to patients with a preexisting deﬁ-
ciency, improved wound healing drastically. Furthermore, the oral
administration of these doses of ascorbic acid is not harmful to pa-
tients, due to the tight control of its absorption and urinary excretion.
Other, important beneﬁts are the low costs of ascorbic acid supple-
mentation together with the likely reduction of expenses caused
by extensive wound care. It should therefore be considered to sup-
plement patients suffering from poor wound healing with at least
2 × 500 mg or 1000 mg a day until the healing process is ﬁnished.
If a patient needs to undergo surgery while being deﬁcient, it is sug-
gested that he/she should start supplemention with ascorbic acid
post-surgery, during a normoxic state to prevent possible damage
caused by its pro-oxidant effects, although evidence for its harmful
effects seems largely hypothetical. One should keep in mind that
such invasive procedures, even more if accompanied by severe in-
fections or sepsis, could lead to a detrimental depletion of ascorbic
acid storage. Finally, we recommend to carefully monitor patients
for an ascorbic acid deﬁciency (signs and symptoms as well as mea-
suring plasma ascorbic acid levels) pre- and post-surgery to prevent
future cases like these, especially in those patients who are at risk
for having a pre-existing ascorbic acid deﬁciency, and those suf-
fering from vascular disease. Our cases demonstrate that treating
deﬁcient patients with ascorbic acid leads to swift improvement of
the wound healing process post-surgery, thereby reducing the costs
of elaborate wound treatment and extensive stay in hospital.
The work described here has been reported in line with the CARE
criteria [18].
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